Financials
Financial year 2025
Medicem from Hoogstraten, company number BE0418885986, closed financial year 2025 with a result of € 71,290 after tax. Compared with financial year 2024, the result moved from € 144,185 to € 71,290. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ 967,760
▲ 8% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 71,290
▼ 51% vs 2024
Profit after tax over the fiscal year.
€ 22,945
▲ € 17,417 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 567,760.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 8,148
▼ 68% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 23 days on average.
€ 34,631
▲ 148% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Profit after taxes | € 852,517 | € 9,393 | € 144,185 | € 71,290 | ▼ 51% |
| Equity | € 742,892 | € 752,285 | € 896,471 | € 967,760 | ▲ 8% |
| Total debts | € 1,266,098 | € 128,448 | € 42,071 | € 45,354 | ▲ 8% |
| Cash | € 52,227 | € 17,587 | € 5,528 | € 22,945 | ▲ € 17,417 |
| Retained profit | € 342,892 | € 352,285 | € 496,471 | € 567,760 | ▲ 14% |
| Dividend | € 1,250,000 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 2,008,990 | € 880,733 | € 938,541 | € 1,013,114 | ▲ 8% |
Key figures of Medicem, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Medicem?
What happened at Medicem in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 71,290 (▼ 51% vs 2024). Source: NBB ↗
- Voxdale NV became a director. NBB
- New establishment in Hoogstraten. KBO
- Start of the company according to the CBE. KBO
In short
From € 852,517 profit in 2022 to € 71,290 profit in 2025.
Paid € 364,394 in corporate taxes since 2022.
Best year ever: 2022, with € 852,517 profit.
Paid out € 1.3 million in dividends to the owners in total.
Management
The stake of VOXDALE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
MedicemBehind Medicem is Voxdale NV. The shares are held by VOXDALE (99.6%).
Directors
According to the 2025 annual accounts
Director · represented by Pascal BEYENS
Also active at: KELA - Kempisch Laboratorium - Kela Laboratoria, KELA VETERINARIA, PHENIX PROPERTY
since 2023
Shareholders
99.6%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Sint Lenaartseweg 48
2320 Hoogstraten
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0418.885.986
- VAT number
- BE 0418.885.986
- Registered office
- Sint Lenaartseweg 48, 2320 Hoogstraten
- Names & denominations
- Medicem
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 7 November 1978
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten